鍋倉宰 Tsukasa Nabekura

鍋倉 宰 研究業績一覧

国際テニュアトラック期間の業績一覧です。

  ➡ プロフィールページへ

 

論文/Papers

6. Tracking the fate of antigen-specific versus cytokine-activated natural killer cells after cytomegalovirus infection.

The Journal of Experimental Medicine, 2016, in press

Tsukasa Nabekura, Lewis L. Lanier

 

5. Activating Receptors for Self-MHC Class I Enhance Effector Functions and Memory Differentiation of NK Cells during Mouse Cytomegalovirus Infection

Immunity, 45, 74-82, 2016

Tsukasa Nabekura, Lewis L. Lanier

 

4. IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse cytomegalovirus infection

The Journal of Immunology, 194, 5948-5952, 2015

Tsukasa Nabekura, Jean-Philippe Girard, and Lewis L. Lanier

 

3. Increased CD11b+ Gr-1+ cell population in the placenta after infection with Toxoplasma gondii

Microbiology and Immunology, 59, 95-98, 2015

Kinuko Takeshima, Kazuki Sato, Tsukasa Nabekura, Kisaburo Nagamune, Hiromi Hamada, Hiroyuki Yoshikawa, Akira Shibuya, Kazuko Shibuya

 

2. Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation

The Journal of Experimental Medicine, 211, 2455-2465, 2014

Tsukasa Nabekura and Lewis L. Lanier

 

1. PPARβ/δ activation of CD300a controls intestinal immunity

Scientific Reports, 4, 5412, 2014

Toshiya Tanaka, Satoko Tahara-Hanaoka, Tsukasa Nabekura, Kaori Ikeda, Shuying Jiang, Shuichi Tsutsumi, Takeshi Inagaki, Kenta Magoori, Takuma Higurashi, Hirokazu Takahashi, Keisuke Tachibana, Yuya Tsurutani, Sana Raza, Motonobu Anai, Takashi Minami, Youichiro Wada, Koutaro Yokote, Takefumi Doi, Takao Hamakubo, Johan Auwerx, Frank Gonzalez, Atsushi Nakajima, Hiroyuki Aburatani, Makoto Naito, Akira Shibuya, and Tatsuhiko Kodama

 

研究費/Grant

1. Grant for Japanese young investigators, the Nakajima Foundation 2015

1. Grant for young investigators, Friends of Leukemia Research Fund 2014

特許/Patent

1. Use of Celiac disease-associated CD300a gene-deficient mouse, activity modulator for CD300a-expressing cells, and medical and pharmaceutical agent comprising activity modulators for CD300a-expressing cells. 2014, #2014-95570, Japan Patent Office

 

国際学会発表/Presentations

1. ===

セミナー・ワークショップ/Seminars

1. ===